1. Hand‐foot‐skin reaction related to use of the multikinase inhibitor sorafenib and hard orthotics
   Ayan Kusari et al, 2018, Pediatric Dermatology CrossRef
2. Adverse reactions and adherence to capecitabine: A prospective study in patients with gastrointestinal cancer
   Marília B Visacri et al, 2022, Journal of Oncology Pharmacy Practice CrossRef
3. Management of skin adverse reactions in oncology
   Diva Silva et al, 2020, Journal of Oncology Pharmacy Practice CrossRef
4. A Case Report of Capecitabine-Associated Bowel Inflammation With a Novel Mutation of the DPYD Gene
   Lukas Schlager et al, 2020, AJSP: Reviews and Reports CrossRef
5. Ichthyosiform Pityriasis Rubra Pilaris-Like Eruption Secondary to Ponatinib Therapy: Case Report and Literature Review
   Ariel E. Eber et al, 2017, Drug Safety - Case Reports CrossRef
6. Predictive factors for the development of capecitabine-induced hand-foot syndrome: a retrospective observational cohort study
   Chaichana Chantharakhit et al, 2023, Annals of Medicine & Surgery CrossRef
7. Topical Retinoids: Therapeutic Mechanisms in the Treatment of Photodamaged Skin
   Ryan R. Riahi et al, 2016, American Journal of Clinical Dermatology CrossRef
8. Advancement of All-Trans Retinoic Acid Delivery Systems in Dermatological Application
   Sharifah Shakirah Syed Omar et al, 2022, Cosmetics CrossRef
9. Uracil-tegafur vs fluorouracil as postoperative adjuvant chemotherapy in Stage II and III colon cancer
   Po-Huang Chen et al, 2021, Medicine CrossRef
10. Breast cancer: insights in disease and influence of drug methotrexate
    Vítor Yang et al, 2020, RSC Medicinal Chemistry CrossRef
11. Detection of capecitabine (Xeloda®) on the skin surface after oral administration
    Mao-Dong Huang et al, 2016, Journal of Biomedical Optics CrossRef
12. Carotenoids in Human Skin In Vivo: Antioxidant and Photo-Protectant Role against External and Internal Stressors
    Maxim E. Darvin et al, 2022, Antioxidants CrossRef